MolNFT v1 · #89107 · protein
The sar development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia
4DFF · Camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase…: “The sar development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the…”. X-ray diffraction, 3 ligands (0JP, MG, ZN), 6 pockets (best…
- PDB
- 4DFF
- Type
- protein
- Length
- 584 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A
- EC
- 3.1.4.17, 3.1.4.35
- UniProt
- Q9Y233
- Ligands
- 0JP, MG, ZN
- Pockets
- 6 · best druggability 0.73
Structure
x-ray diffraction · 2 distinct chains · 72% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17, 3.1.4.35) | protein | 307 | 74% helix, 0% strand | Q9Y233 |
| B | Camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17, 3.1.4.35) | protein | 277 | 71% helix, 0% strand | Q9Y233 |
Ligands and binding sites
- 0JP · 8,9-dimethoxy-1-(1,3-thiazol-5-yl)-5,6-dihydroimidazo[5,1-a]isoquinoline · ligand · chains B
- MG · Magnesium ion · metal · 2 copies · chains A, B
- ZN · Zinc ion · metal · 2 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 395 | 0.73 | 0.83 | 49 | MG |
| 2 | 552 | 0.72 | 0.80 | 57 | 0JP, MG |
| 3 | 577 | 0.72 | 0.80 | 62 | empty |
| 4 | 93 | 0.40 | 0.77 | 21 | empty |
| 5 | 102 | 0.38 | 0.75 | 21 | empty |
Interfaces
1 interface between chains.
- A–B · 822 Ų buried · 11 hydrogen bonds · protein-protein
Compared structures
- 4DFF · The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9Y233
- Elsewhere: RCSB PDB 4DFF · PDBe 4DFF · UniProt Q9Y233
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.